Frontiers in Genetics (Jan 2024)

Case report: A founder UGDH variant associated with developmental epileptic encephalopathy in Saudi Arabia

  • Manal Alaamery,
  • Manal Alaamery,
  • Manal Alaamery,
  • Salam Massadeh,
  • Salam Massadeh,
  • Salam Massadeh,
  • Manar Aldarwish,
  • Manar Aldarwish,
  • Nour Albesher,
  • Nour Albesher,
  • Nora Aljawini,
  • Othman Alahmed,
  • Amna Kashgari,
  • Amna Kashgari,
  • Christopher A. Walsh,
  • Wafaa Eyaid,
  • Wafaa Eyaid

DOI
https://doi.org/10.3389/fgene.2023.1294214
Journal volume & issue
Vol. 14

Abstract

Read online

Congenital disorders of glycosylation (CDG) are a group of more than 100 rare genetic disorders characterized by impaired glycosylation of proteins and lipids. The clinical presentation of CDG varies tremendously, from single-organ to multi-organ involvement and from prenatal death to a normal adult phenotype. In this case study, we report a large consanguineous family with multiple children suffering from cerebral palsy, seizure, developmental and epileptic encephalopathy, and global developmental delay. Whole-exome sequencing (WES) analysis revealed a homozygous variant in the UDP-glucose dehydrogenase (UGDH) gene (c.950G>A; p.R317Q) which segregates with the familial phenotype with a plausible autosomal recessive mode of inheritance, indicating a potential disease-causing association. The UGDH gene encodes the UDP-glucose dehydrogenase, a key enzyme in the synthesis of specific extracellular matrix constituents (proteoglycans and glycolipids) involved in neural migration and connectivity during early brain development. Many pathogenic mutations of UGDH have been reported in recent literature works. However, the variant identified in this study has been observed only in the Saudi population (13 families) and not in any other ethnic background, suggesting that it may be an ancient founder mutation.

Keywords